Manejo de la dislipemia aterogénica en Atención Primariadescripción de la práctica clínica habitual (Estudio Avanza)

  1. Capón Álvarez, Jessica
unter der Leitung von:
  1. Jesús Seco Calvo Doktorvater/Doktormutter
  2. Ángel Díaz Rodríguez Doktorvater/Doktormutter

Universität der Verteidigung: Universidad de León

Fecha de defensa: 28 von Januar von 2021

Gericht:
  1. José L. Mauriz Präsident/in
  2. Vicente Rodríguez Pérez Sekretär/in
  3. Luis Alberto Rodríguez Arroyo Vocal
Fachbereiche:
  1. DEP. DE ENFERMERÍA Y FISIOTERAPIA

Art: Dissertation

Zusammenfassung

Atherogenic Dyslipemia (DA) is an alteration of lipid and lipoprotein metabolism. It is characterized by the presence of low levels of cholesterol transported by high density lipoproteins (HDL), hypertriglyceridemia and a high proportion of LDL (LDL: low density lipoproteins) small and dense, with or without a moderate increase in cLDL. This type of dyslipemia is associated with a high cardiovascular risk and contributes significantly to lipid residual vascular risk. It is also a very common lipoprotic phenotype and is associated with obesity, insulin resistance, coronary heart disease, metabolic syndrome, or type 21 diabetes mellitus (DM) .